277 related articles for article (PubMed ID: 27816512)
21. Increased Soluble Suppression of Tumorigenicity 2 Level Predicts All-Cause and Cardiovascular Mortality in Maintenance Hemodialysis Patients: A Prospective Cohort Study.
Zhang Z; Shen B; Cao X; Liu Z; Chen X; Nie Y; Yu J; Zou J; Ding X
Blood Purif; 2017; 43(1-3):37-45. PubMed ID: 27875808
[TBL] [Abstract][Full Text] [Related]
22. sST2 adds to the prognostic value of Gal-3 and BNP in chronic heart failure.
Barutaut M; Fournier P; Peacock WF; Evaristi MF; Dambrin C; Caubère C; Koukoui F; Galinier M; Smih F; Rouet P
Acta Cardiol; 2020 Dec; 75(8):739-747. PubMed ID: 31560863
[No Abstract] [Full Text] [Related]
23. The prognostic value of plasma soluble ST2 in hospitalized Chinese patients with heart failure.
Zhang R; Zhang Y; Zhang J; An T; Huang Y; Guo X; Januzzi JL; Cappola TP; Yin S; Wang Y; Zhou Q; Zou C; Ji S; Lv R
PLoS One; 2014; 9(10):e110976. PubMed ID: 25347817
[TBL] [Abstract][Full Text] [Related]
24. Prognostic role of ST2 in patients with chronic heart failure of ischemic etiology and carbohydrate metabolism disorders.
Grakova EV; Kopeva KV; Teplyakov AT; Ogurkova ON; Garganeeva AA; Garmaeva OV
Ter Arkh; 2019 Mar; 91(1):32-37. PubMed ID: 31090368
[TBL] [Abstract][Full Text] [Related]
25. Prognostic value of soluble ST2 and soluble LR11 on mortality and cardiovascular events in peritoneal dialysis patients.
Choi YB; Lee MJ; Park JT; Han SH; Kang SW; Yoo TH; Kim HJ
BMC Nephrol; 2020 Jun; 21(1):228. PubMed ID: 32539731
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of soluble ST2 biomarker in heart failure patients with reduced ejection fraction - A multicenter study.
Bahuleyan CG; Alummoottil GK; Abdullakutty J; Lordson AJ; Babu S; Krishnakumar VV; Pillai AM; Abraham G; Dilip MN
Indian Heart J; 2018 Jul; 70 Suppl 1(Suppl 1):S79-S84. PubMed ID: 30122243
[TBL] [Abstract][Full Text] [Related]
27. Independent and incremental prognostic value of novel cardiac biomarkers in chronic hemodialysis patients.
Obokata M; Sunaga H; Ishida H; Ito K; Ogawa T; Ando Y; Kurabayashi M; Negishi K
Am Heart J; 2016 Sep; 179():29-41. PubMed ID: 27595677
[TBL] [Abstract][Full Text] [Related]
28. Soluble Urokinase-Type Plasminogen Activator Receptor Improves Risk Prediction in Patients With Chronic Heart Failure.
Koller L; Stojkovic S; Richter B; Sulzgruber P; Potolidis C; Liebhart F; Mörtl D; Berger R; Goliasch G; Wojta J; Hülsmann M; Niessner A
JACC Heart Fail; 2017 Apr; 5(4):268-277. PubMed ID: 28359415
[TBL] [Abstract][Full Text] [Related]
29. Serum suppression of tumorigenicity 2 level is an independent predictor of all-cause mortality in HIV-infected patients.
Thiébaut R; Hue S; Le Marec F; Lelièvre JD; Dupon M; Foucat E; Lazaro E; Dabis F; Duffau P; Wittkop L; Surenaud M; Pellegrin I; Lacabaratz C; Bonnet F; Lévy Y;
AIDS; 2017 Nov; 31(17):2355-2365. PubMed ID: 29068834
[TBL] [Abstract][Full Text] [Related]
30. Soluble ST2 for predicting sudden cardiac death in patients with chronic heart failure and left ventricular systolic dysfunction.
Pascual-Figal DA; Ordoñez-Llanos J; Tornel PL; Vázquez R; Puig T; Valdés M; Cinca J; de Luna AB; Bayes-Genis A;
J Am Coll Cardiol; 2009 Dec; 54(23):2174-9. PubMed ID: 19942089
[TBL] [Abstract][Full Text] [Related]
31. Soluble ST2 has a prognostic role in patients with suspected sepsis.
Hur M; Kim H; Kim HJ; Yang HS; Magrini L; Marino R; Cardelli P; Di Somma S;
Ann Lab Med; 2015 Nov; 35(6):570-7. PubMed ID: 26354344
[TBL] [Abstract][Full Text] [Related]
32. Clinical and Prognostic Significance of sST2 in Heart Failure: JACC Review Topic of the Week.
Aimo A; Januzzi JL; Bayes-Genis A; Vergaro G; Sciarrone P; Passino C; Emdin M
J Am Coll Cardiol; 2019 Oct; 74(17):2193-2203. PubMed ID: 31648713
[TBL] [Abstract][Full Text] [Related]
33. Head-to-head comparison of serial soluble ST2, growth differentiation factor-15, and highly-sensitive troponin T measurements in patients with chronic heart failure.
Gaggin HK; Szymonifka J; Bhardwaj A; Belcher A; De Berardinis B; Motiwala S; Wang TJ; Januzzi JL
JACC Heart Fail; 2014 Feb; 2(1):65-72. PubMed ID: 24622120
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure.
Tang WH; Wu Y; Grodin JL; Hsu AP; Hernandez AF; Butler J; Metra M; Voors AA; Felker GM; Troughton RW; Mills RM; McMurray JJ; Armstrong PW; O'Connor CM; Starling RC
JACC Heart Fail; 2016 Jan; 4(1):68-77. PubMed ID: 26656144
[TBL] [Abstract][Full Text] [Related]
35. Increased plasma concentrations of soluble ST2 are predictive for 1-year mortality in patients with acute destabilized heart failure.
Mueller T; Dieplinger B; Gegenhuber A; Poelz W; Pacher R; Haltmayer M
Clin Chem; 2008 Apr; 54(4):752-6. PubMed ID: 18375488
[TBL] [Abstract][Full Text] [Related]
36. Soluble ST2 in heart failure.
Dieplinger B; Mueller T
Clin Chim Acta; 2015 Mar; 443():57-70. PubMed ID: 25269091
[TBL] [Abstract][Full Text] [Related]
37. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
[TBL] [Abstract][Full Text] [Related]
38. Soluble concentrations of the interleukin receptor family member ST2 and β-blocker therapy in chronic heart failure.
Gaggin HK; Motiwala S; Bhardwaj A; Parks KA; Januzzi JL
Circ Heart Fail; 2013 Nov; 6(6):1206-13. PubMed ID: 24114865
[TBL] [Abstract][Full Text] [Related]
39. Soluble suppression of tumorigenesis-2 is a strong predictor of all-cause, cardiovascular and infection-related mortality risk in haemodialysis patients with diabetes mellitus.
Hammer F; Genser B; Dieplinger B; Egger M; Müller T; Drechsler C; März W; Störk S; Wanner C; Krane V
Clin Kidney J; 2022 Oct; 15(10):1915-1923. PubMed ID: 36158148
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic and prognostic value of serum soluble suppression of tumorigenicity-2 in heart failure with preserved ejection fraction: A systematic review and meta-analysis.
Shi Y; Liu J; Liu C; Shuang X; Yang C; Qiao W; Dong G
Front Cardiovasc Med; 2022; 9():937291. PubMed ID: 36204571
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
